Among the prothrombotic mechanisms of cancer described above, increased levels of leukocytes, NETs, tissue factor-positive (TF+) microvesicles (MVs), and endothelial cell activation exerted an important role in lung cancer patients [15,16]. The gene discussed is TF; the disease is cancer.